Insider · CIK 0001219871
MOTT DAVID M
Reports to the SEC for 50 companies · GAITHERSBURG, MD
Transactions
50
Companies
50
Filings
4
CIK
0001219871
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-20 | NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion | — |
| 2026-06-20 | NVAXNOVAVAX INCM Exercise/Conversion | — |
| 2026-06-18 | NVAXNOVAVAX INC · Stock Option (Right to Buy)A Award | — |
| 2026-06-18 | NVAXNOVAVAX INC · Restricted Stock UnitsA Award | — |
| 2026-06-16 | ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award | — |
| 2026-06-16 | ARDXARDELYX, INC.A Award | — |
| 2026-06-16 | ARDXARDELYX, INC.A Award | — |
| 2026-02-20 | ARDXARDELYX, INC.P Purchase | +$1.95M |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc.U Disposition from Tender | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc.U Disposition from Tender | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2026-01-06 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-06-20 | NVAXNOVAVAX INC · Stock Option (Right to Buy)A Award | +$182K |
| 2025-06-20 | NVAXNOVAVAX INC · Restricted Stock UnitsA Award | — |
| 2025-06-18 | ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-06-18 | ARDXARDELYX, INC.A Award | — |
| 2025-06-18 | ARDXARDELYX, INC.A Award | — |
| 2025-06-16 | ARDXARDELYX, INC.P Purchase | +$726K |
| 2025-06-12 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2025-06-12 | NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-06-12 | NVAXNOVAVAX INCM Exercise/Conversion | — |
| 2025-06-09 | ARDXARDELYX, INC.P Purchase | +$737K |
| 2025-05-15 | ARDXARDELYX, INC.P Purchase | +$329K |
| 2025-05-02 | ARDXARDELYX, INC.P Purchase | +$1.61M |
| 2025-02-24 | ARDXARDELYX, INC.P Purchase | +$389K |
| 2025-01-21 | ARDXARDELYX, INC.P Purchase | +$993K |
| 2024-12-26 | ARDXARDELYX, INC.M Exercise/Conversion | +$55K |
| 2024-12-26 | ARDXARDELYX, INC. · Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2024-12-19 | ARDXARDELYX, INC.P Purchase | +$997K |
| 2024-11-13 | ARDXARDELYX, INC.P Purchase | +$997K |
| 2024-07-01 | ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award | — |
| 2024-06-14 | ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award | — |
| 2024-06-14 | ARDXARDELYX, INC.A Award | — |
| 2024-06-12 | NVAXNOVAVAX INC · Restricted Stock UnitsA Award | — |
| 2024-06-12 | NVAXNOVAVAX INC · Stock Option (Right to Buy)A Award | +$248K |
| 2024-06-12 | NVAXNOVAVAX INC · Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-06-12 | NVAXNOVAVAX INCM Exercise/Conversion | — |
| 2024-06-11 | MRSNMersana Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2024-01-02 | MRSNMersana Therapeutics, Inc.A Award | — |
Recent filings
- 4MOTT DAVID M0001104659-26-076925SEC(opens sec.gov)
- 4MOTT DAVID M0001219871-26-000003SEC(opens sec.gov)
- 4MOTT DAVID M0001610717-26-000066SEC(opens sec.gov)
- 4MOTT DAVID M0001104659-26-001368SEC(opens sec.gov)
Companies
- Achaogen, Inc.10% Owner
- Adaptimmune Therapeutics PLCDirectorADAP
- AEROHIVE NETWORKS, INC10% Owner
- APPIAN CORP10% OwnerAPPN
- ARDELYX, INC.DirectorARDX
- Avalo Therapeutics, Inc.10% OwnerAVTX
- AVEO PHARMACEUTICALS, INC.10% Owner
- Black Diamond Therapeutics, Inc.10% OwnerBDTX
- BOX INC10% OwnerBOX
- Care.com Inc10% Owner
- Cascadian Therapeutics, Inc.10% Owner
- Casper Sleep Inc.10% Owner
- CHAMPIONS ONCOLOGY, INC.10% OwnerCSBR
- Cloudflare, Inc.10% OwnerNET
- Clovis Oncology, Inc.10% Owner
- CRESCENT BIOPHARMA, INC.10% OwnerCBIO
- CVENT INC10% Owner
- Dermira, Inc.10% Owner
- Elastic N.V.10% OwnerESTC
- Enliven Therapeutics, Inc.DirectorELVN
- Epizyme, Inc.Director
- Galera Therapeutics, Inc.10% OwnerGRTX
- GENOCEA BIOSCIENCES, INC.10% Owner
- INTERLEUKIN GENETICS INC10% Owner
- Loxo Oncology, Inc.10% Owner
- Marker Therapeutics, Inc.10% OwnerMRKR
- MEDIMMUNE INC /DEDirector, Vice Chair. of the Board, CEO
- Mersana Therapeutics, Inc.DirectorMRSN
- Millennial Media Inc.10% Owner
- Mirum Pharmaceuticals, Inc.10% OwnerMIRM
- MULESOFT, INC10% Owner
- Nightstar Therapeutics plcDirector, 10% Owner
- NOVAVAX INCDirectorNVAX
- Omthera Pharmaceuticals, Inc.Director, 10% Owner
- Oruka Therapeutics, Inc.10% OwnerORKA
- Oyster Point Pharma, Inc.10% Owner
- PhaseBio Pharmaceuticals Inc10% Owner
- Ra Pharmaceuticals, Inc.10% Owner
- Regulus Therapeutics Inc.10% Owner
- RHYTHM PHARMACEUTICALS, INC.10% OwnerRYTM
- Sorrento Tech, Inc.10% Owner
- Sprout Social, Inc.10% OwnerSPT
- Surface Oncology, Inc.10% Owner
- SYNLOGIC, INC.10% OwnerSYBX
- Tempest Therapeutics, Inc.10% OwnerTPST
- TESARO, Inc.Director, 10% Owner
- Tracon Pharmaceuticals, Inc.10% Owner
- Trevi Therapeutics, Inc.10% OwnerTRVI
- Workday, Inc.10% OwnerWDAY
- X4 Pharmaceuticals, Inc10% OwnerXFOR
Address
21 FIRSTFIELD ROAD
GAITHERSBURG, MD, 20878